Salonpas (methyl salicylate/menthol) / Hisamitsu - LARVOL DELTA

"Me too BYOT and salonpas!" (@christinemphmd)

Development, In Vitro and Ex-Vivo Assessment of Capsaicin Liposomal Film for Dermal Delivery. (PubMed, Recent Pat Nanotechnol) - "The CAP-Liposomes were successfully developed using ethanol injection method for transdermal delivery. It was found that CAP solubility was enhanced by intercalating in to the phospholipid fatty acids, increased encapsulation and loading efficiency. From the release studies, The Lipofilm shown prolonged permeation compared to marketed patch (SALONPAS®) and plain film across rat skin. Hence the liposomes are considered as an alternative potential tool to anti-inflammatory for effective dermal delivery."

Journal • Preclinical

"@homedepot @salonpas @pfizer" (@adamholden69)

Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches (clinicaltrials.gov) - P1; N=24; Completed; Sponsor: Scilex Pharmaceuticals, Inc.

Clinical • New P1 trial • Pain

[VIRTUAL] The role of self-efficacy in chronic pain-A case report relating motivation during the COVID-19 pandemic and a patient with chronic pain (ACRM 2021) - "The medications she was using for pain included Naproxen, and the patient also found relief with Salonpas pain relief patches.Interventions: 1. This case is an example of someone with chronic low back pain that prior to the pandemic, had enough self efficacy to manager her condition independently. Interventions during physical therapy focused on traditional manual and therapeutic exercise principles as well as physiological components aimed to improve her self-efficacy."

Clinical • Back Pain • Immunology • Infectious Disease • Lumbar Back Pain • Musculoskeletal Pain • Novel Coronavirus Disease • Pain • Rheumatology • Seronegative Spondyloarthropathies

Personalized Pain Therapy: An Artificial Intelligence (AI) Method and Web-Tool to Predict Patient Response to OTC Topical Analgesics (PAINWeek 2021) - "In particular, the machine learning method is complemented with pre- and post-modelling explainability modules, and applied to individualize the therapy of chronic pain patients. This machine learning project applied AI and analyzed the results of a study on a specific topical analgesic- the Salonpas® Pain Relieving Patch- in attempt to predict which patients would experience analgesic benefits."

Clinical • CNS Disorders • Pain • Psychiatry

NAD Finds Salonpas Duration Claim Supported; Recommends Hisamitsu America Discontinue Comparative Pain Relief, Onset of Action, Range of Motion Claims (PRNewswire) - "The National Advertising Division (NAD)...determined that Hisamitsu provided a reasonable basis for the challenged claims comparing the Salonpas patch's regulatory pathway to competitor products...The advertiser's Salonpas patch is a topical patch imbued with medicine and is currently marketed under an FDA approved New Drug Application...To support its claim that 'All OTC pain relievers, including Voltaren, have one thing in common. None are proven stronger or more effective against pain than Salonpas Pain Relief Patch Large,'. Hisamitsu provided no evidence that its product is as strong or efficacious as Voltaren for the treatment of arthritic pain. In the absence of such evidence, NAD recommended that the claim be discontinued...during the proceeding, the advertiser voluntarily permanently discontinued claims that it was the 'only FDA-approved OTC topical pain reliever,' therefore NAD did not review these claims on the merits."

Review • Osteoarthritis • Pain

"#FireHannity @exxonmobil @harvestright @hp @Salonpas @hulu @Hyundai @JohnDeere @LibertyMutual @loanDepot" (@poseswim)

"Yes! And I just discovered SalonPas gel with Lidocaine. Oh my goodness- huge difference!" (@InduPartha)

Improvement of Pain and Function After Use of a Topical Pain Relieving Patch: Results of the RELIEF Study. (PubMed, J Pain Res) - "No side effects of treatment were reported. Results indicate that this topical analgesic pain-relieving patch can reduce BPI pain severity and interference scores in adult patients with mild to moderate arthritic, neurological, and musculoskeletal pain and should be considered as a treatment option."

Journal • Back Pain • Musculoskeletal Diseases • Musculoskeletal Pain • Pain

The Journal of Pain Research Features the Publication of the RELIEF Study, a Topical Analgesic Pain Relief Study Conducted by Clarity Science (Benzinga) - P=NA, N=199; "Hisamitsu America, the marketers of Salonpas®, announce today that The Journal of Pain Research...features the publication, in June 2020, of the RELIEF study: 'Relieving Pain: Evaluating Patient Quality of Life Improvement - Perceptions, Experience and Feedback After Use of a Topical Pain Relief Patch'...Pain severity in treated patients decreased significantly, by 49.0% compared to 12.3% in patients in the control group, while function significantly improved by 58.1% compared to 14.8% in patients in the control group. Additionally, no side effects of treatment were reported."

Clinical data • Back Pain • Musculoskeletal Pain • Pain

"@IngrahamAngle is a sorry human being Let her advertisers know @SandalsResorts @LifeLock @Nutrisystem @southbeachdiet @MyPillowUSA @safelite @WeatherTech @tecovas @Bayer @AgelessMale_usa @SHEEX @Prevagen @bookingcom @flonase @StampsCom @CoinJewelryExch @SeroVital @pray @salonpas" (@RalyDee)

"Do you care?@bookingcom @Salonpas @sanofi @Prevagen @flonase @SeroVital @StampsCom @Clearchoicedental" (@Frankie12559230)

"Adding these to the list if @FoxNews advertisers: @VW @ADT @salonpas @NewDayUSA @Bayer @LifeLock @TMobile @DrScholls @OldDominion @Voya #FireDonna @jayawallace #FireDonnaBrazile" (@EnBolden2)

"Holistic Diabetic Neuropathy Treatments – Salonpas® https://t.co/7eGGXpn5fH" (@Myeloma_Doc)